The reduction in myocardial collagen deposition in response to AR inhibition in mice with type 2 diabetes, suggests the noteworthy possibility that decreases in fatty acid oxidation may improve diastolic function by decreasing fibrosis. Here, AR is linked to type 2 diabetes mellitus.